{
    "2020-11-19": [
        [
            {
                "time": "",
                "original_text": "此次采集政策利好冠脉支架龙头企业，最终会使",
                "features": {
                    "keywords": [
                        "政策利好",
                        "冠脉支架",
                        "龙头企业"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗设备",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "下一个PD-1：CD47靶点大热，天境生物Lemzoparlimab突破安全性难题，率先展现潜在疗效",
                "features": {
                    "keywords": [
                        "PD-1",
                        "CD47靶点",
                        "天境生物",
                        "Lemzoparlimab",
                        "安全性",
                        "潜在疗效"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}